Launch of the European project RISK-HUNT3R The new Horizon 2020 project RISK-HUNT3R: RISK assessment of chemicals integrating HUman centric Next generation Testing strategies promoting the 3Rs was launched on 1 June.
Effects of COVID-19 vaccination becoming increasingly visible In the past calendar week, there were 43% fewer hospital admissions of patients with COVID-19 compared to the week before.
People born in 1981 invited for COVID-19 vaccination As of today, people born in 1981 can schedule an appointment online via www.coronavaccinatie-afspraak.nl for vaccination by the Municipal Public Health Services (GGDs).
Higher mortality during heatwave in July in the Netherlands During the last heatwave, almost 400 more deaths were reported than was expected on overage for that period. The additional deaths mainly concerned persons aged 75 years and older.
Summary International Expert Meeting on breast implant-associated lymphoma On November 19th 2018, RIVM organised an international expert meeting on a rare type of lymphoma that is associated with breast implants.
No decline in CO2 emissions since 1990 Dutch greenhouse gas emissions were 13 per cent lower in 2017 than in 1990. Emissions have been almost constant over the past five years.
RIVM will make measurements around the Sint Maarten landfill From 21 January 2019, a team from RIVM will travel to Sint Maarten to make measurements and take samples at various locations around the landfill in Philipsburg.
Explanation for difference in development ammonia emissions and concentrations Since 2005, higher ammonia concentrations have been measured in the air, despite registered emissions decreasing. New RIVM research shows that three-quarters of this difference can be explained by changes in atmospheric and chemical processes.
No health risks associated with foods and food supplements containing Krill and microalgae oils Consumption of foods and food supplements that contain oil from microalgae Schizochytrium sp. and Krill oil do not cause harm to our health.
No evidence of increased incidence of breast cancer with insulin glargine Insulin glargine is used in the treatment of diabetes.